文献速递淋巴瘤造血干细胞移植与细胞治疗

成人T细胞白血病/淋巴瘤异基因造血干细胞移植后染色体缺陷与生存的相关性

Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT.
PubMed 文献 · Blood Adv · 2021-01-01

本研究基于日本全国登记数据库分析300例接受异基因造血干细胞移植的成人T细胞白血病/淋巴瘤患者,中位年龄55岁,多数为急性型。生存分析显示2q和5q断裂点是总生存的显著不良预后因素,染色体14缺失及3p、1q、5q、6q断裂点与ATL相关死亡显著相关,复杂核型亦与ATL相关死亡相关。

要点

  • 2q和5q断裂点是移植后总生存的独立不良预后因素
  • 染色体14缺失及3p、1q、5q、6q断裂点与ATL相关死亡显著相关
  • 复杂核型与ATL相关死亡相关

核心结论

  • 多个结构断裂点是接受异基因造血干细胞移植的ATL患者总生存和ATL相关死亡的独立危险因素。

研究设计与样本

  • 回顾性分析日本全国登记数据库中300例接受异基因造血干细胞移植的ATL患者,中位年龄55岁(范围24-74岁),其中183例为急性ATL。

主要发现

  • 染色体14缺失及3p、1q、5q、6q断裂点是ATL相关死亡的显著不良预后因素。
  • 复杂核型与ATL相关死亡相关。

临床怎么用

  • 对接受异基因造血干细胞移植的ATL患者,可关注染色体2q和5q断裂点等结构异常以辅助预后评估。

局限性

  • 染色体分析标本来源多样(骨髓166例、淋巴结86例、外周血41例、其他部位7例),可能影响结果一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adult T-cell leukemia/lymphoma (ATL) cells frequently exhibit chromosomal abnormalities, including numerical aberrations and structural defects. However, no studies have examined the correlation between these abnormalities and survival in patients with ATL after allogeneic HSCT (allo-HSCT). In this study, 300 patients with ATL (median age, 55 years; range, 24-74) who were registered in a Japanese nationwide registry database were analyzed. The majority (n = 183) had acute ATL. Specimens for chromosomal analysis were collected from bone marrow (n = 166), lymph nodes (n = 86), peripheral blood (n = 41), and other locations (n = 7). In survival analyses, breakpoints at 2q (hazard ratio [HR], 1.63; 95% confidence interval [CI], 1.12-2.38; P = .012) and 5q (HR, 2.18; 95% CI, 1.25-3.80; P = .006) were significantly poor prognostic factors for overall survival (OS). In terms of ATL-related death, loss of chromosome 14 and breakpoints at 3p, 1q, 5q, and 6q were extracted as significantly poor prognostic factors. Moreover, complex karyotypes were associated with ATL-related death. This study of the survival impact of chromosomal abnormalities in patients with ATL after allo-HSCT demonstrated that several structural breakpoints were independent risk factors for OS and ATL-related death.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Nakano N, Utsunomiya A, Matsuo K, et al. Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT. Blood Adv. 2021. PMID: 33496743. doi:10.1182/bloodadvances.2020003639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。